Alnylam Pharmaceuticals vs Arrakis Therapeutics
Alnylam Pharmaceuticals vs Arrakis Therapeutics, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Alnylam Pharmaceuticals is on 19/100 and Arrakis Therapeutics on 46/100.
Where each one leads
Alnylam Pharmaceuticals
- agent readiness: 42/100 against 37/100
- domain rating: 72/100 against 29/100
Arrakis Therapeutics
- our overall score: 46/100 against 19/100
At a glance
| Measure | Alnylam Pharmaceuticals | Arrakis Therapeutics |
|---|---|---|
| What it is | Biopharmaceutical company pioneering RNA interference (RNAi) therapeutics to treat rare and prevalent genetic diseases. | Arrakis Therapeutics is a biopharmaceutical company developing oral medicines that target RNA to treat a range of diseases. The company is based in Waltham, Mas |
| Category | Biotechnology, Pharmaceuticals, Healthcare | Biotech, Drug Discovery, RNA Therapeutics, Small Molecule Drugs |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Software |
| Founded | 2002 | 2014 |
| Headquarters | Cambridge, United States | Waltham, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Alnylam Pharmaceuticals | Arrakis Therapeutics |
|---|---|---|
| Employees | Not published | 52 |
| LinkedIn followers | Not published | 12,956 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Alnylam Pharmaceuticals | Arrakis Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 19/100 | 46/100 |
| Traction | Not published | 17/100 |
| Team | 70/100 | Not published |
| Search visibility | 11/100 | 34/100 |
| Quality | Not published | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | F (37/100) |
| Domain ratingLink authority, 0-100 | 72/100 | 29/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Alnylam Pharmaceuticals | Arrakis Therapeutics |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Jquery, Bootstrap | Jquery |
| Analytics | Not detected | Google Analytics 4 |
| Open source | Yes | No |
What users say
| Measure | Alnylam Pharmaceuticals | Arrakis Therapeutics |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 2 positive, 2 negative across 4 threads |
“Pharmaunternehmen - Roche schliesst Lizenzvereinbarung mit Arrakis Therapeutics, Der Pharmakonzern Roche hat sich auf eine Lizenzvereinbarung mit dem US-Biotechunternehmen Arrakis Therapeutics geeinigt..”r/chpresseschau
Alnylam Pharmaceuticals vs Arrakis Therapeutics: common questions
Which is better, Alnylam Pharmaceuticals or Arrakis Therapeutics?
On our 0-100 score Arrakis Therapeutics rates higher (46/100 against 19/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Alnylam Pharmaceuticals and Arrakis Therapeutics compare on the numbers?
Alnylam Pharmaceuticals leads on agent readiness (42/100 against 37/100), domain rating (72/100 against 29/100). Arrakis Therapeutics leads on our overall score (46/100 against 19/100).
What do real users say about Alnylam Pharmaceuticals and Arrakis Therapeutics?
Arrakis Therapeutics: 2 positive and 2 negative mentions across 4 Reddit threads we track, mostly in r/chpresseschau.
Read the full Alnylam Pharmaceuticals review and pricing or the Arrakis Therapeutics review and pricing. You can also browse other Alnylam Pharmaceuticals alternatives we track.